Debora Barton

Debora Barton, MD, is currently the Chief Medical Officer at Full-Life Technologies, overseeing a global radiotherapeutics company dedicated to advancing radiopharmaceutical research and development. In addition to this role, Debora serves as a board member for Deverra Therapeutics and NKILT Therapeutics, and holds advisory positions with NeoGenomics Laboratories and Tigerlily Foundation. Previous experience includes leadership roles at TScan Therapeutics and Carisma Therapeutics, contributing to significant advancements in cellular therapies. Debora's educational background includes medical degrees from Universidade Federal de São Paulo and Pontifícia Universidade Católica de São Paulo, as well as executive education from Columbia Business School and immunology training at Harvard Medical School.